Authors:
STUBBS P
SEED M
LANE D
COLLINSON P
KENDALL F
NOBLE M
Citation: P. Stubbs et al., LIPOPROTEIN(A) AS A RISK PREDICTOR FOR CARDIAC MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES, European heart journal, 19(9), 1998, pp. 1355-1364
Authors:
STUBBS P
COLLINSON P
KENDALL F
NOBIE M
SEED M
Citation: P. Stubbs et al., THE PROGNOSTIC-SIGNIFICANCE OF LIPOPROTEIN(A) CONCENTRATIONS FOLLOWING MYOCARDIAL-INFARCTION, HEART, 75(5), 1996, pp. 249-249
Authors:
ATKIN K
KENDALL F
GOULD D
FREEMAN H
LIEBERMAN J
OSULLIVAN D
Citation: K. Atkin et al., NEUTROPENIA AND AGRANULOCYTOSIS IN PATIENTS RECEIVING CLOZAPINE IN THE UK AND IRELAND, British Journal of Psychiatry, 169(4), 1996, pp. 483-488
Authors:
BARNES MP
BATES D
CORSTON RN
CROWDER D
DICK DJ
EMRE M
FINDLEY LJ
WOOD H
HAWKES CH
HAWKINS SA
HUDGSON P
KENDALL F
JEWITT K
MOFFAT B
MILLAC P
PARK D
PERKIN GD
ROBERTS R
SAGAR H
SPOKES E
Citation: Mp. Barnes et al., A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TIZANIDINE IN THE TREATMENT OF SPASTICITY CAUSED BY MULTIPLE-SCLEROSIS, Neurology, 44(11), 1994, pp. 70-78
Authors:
LONG CC
HILL SA
THOMAS RC
JOHNSTON A
SMITH SG
KENDALL F
FINLAY AY
Citation: Cc. Long et al., EFFECT OF TERBINAFINE ON THE PHARMACOKINETICS OF CYCLOSPORINE IN HUMANS, Journal of investigative dermatology, 102(5), 1994, pp. 740-743